Study Stopped
Patient population was not available
Optimal EGM Configuration for Morphology Discrimination
SVT Morphology
1 other identifier
observational
3
1 country
1
Brief Summary
The study will be a prospective cohort study of 20 patients recruited from site's Defibrillator Clinic patient population who are followed at the site. Hypothesis: Among the available EGM configuration options, one is better than the others for detection enhancements purposes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 24, 2009
CompletedFirst Posted
Study publicly available on registry
April 27, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedFebruary 4, 2019
February 1, 2019
8 months
April 24, 2009
February 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
% morphology match
off line analysis
acute
Study Arms (1)
ICD patient with frequent PVCs
Interventions
10 seconds recording of atrial paced rhythm at 100 ppm in sitting 10 seconds recording of atrial paced rhythm at 150 ppm in supine 10 seconds recording of atrial paced rhythm at 150 ppm in sitting
Eligibility Criteria
Patients with a dual chamber ICD and frequent PVCs
You may qualify if:
- Patients must already have an implanted St. Jude Medical dual chamber ICD with a dual coil defibrillator lead.
- Patients must be willing to sign an informed consent form.
- Patients must have frequent PVCs (minimum of 30/hour)
You may not qualify if:
- Known history of slow VT (under 160 bpm).
- Patients under the age of 18 years.
- Pregnant women.
- Pacemaker dependent rhythm.
- Ongoing angina pectoris.
- Current NYHA Class 3-4 heart failure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Medical Deviceslead
- Unity Health Torontocollaborator
Study Sites (1)
St Michael's Hospital
Toronto, Ontario, M5B1W8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2009
First Posted
April 27, 2009
Study Start
April 1, 2009
Primary Completion
December 1, 2009
Study Completion
May 1, 2010
Last Updated
February 4, 2019
Record last verified: 2019-02